NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma

Clinical trial NCT03524898 · TERMINATED

Trial details

NCT number: NCT03524898
Sponsor: Swiss Cancer Institute
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2018-10-02
Primary completion: 2022-02-15
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.